Skip to content
Open access

Beyond chronological age: identifying accelerated aortic aging through laboratory indicators and geometric phenotyping

Oct 2026 · European Heart Journal · 0 citations

Abstract

The thoracic aorta undergoes significant geometric remodeling with age, which is linked to cardiovascular diseases. However, systematic aging patterns across multiple aortic geometric phenotypes (AGPs) and the potential of routine laboratory tests to reflect aortic "accelerated aging" remain incompletely understood. We aim to systematically evaluate age-related changes in thoracic aortic geometry, assess the independent impact of cardiovascular risk factors, and identify routine laboratory markers associated with accelerated vascular aging. This retrospective cross-sectional study included 1,971 subjects (1,348 females, 623 males; mean age 40.1 ± 10.6 years) in our institution from January 2025 to February 2025. Using non-electrocardiography (ECG)–gated chest CT, 27 AGPs were extracted. Multivariable linear regression was used to evaluate the effects of age, sex, and four cardiovascular risk factors (hypertension, diabetes, smoking, hyperlipidemia) on AGPs. Aortic "accelerated aging" was defined as geometric changes exceeding age- and sex-expected values (model residuals), which were subsequently analyzed against 46 routine laboratory indicators using regression and SHAP analyses. Among 1,887 eligible subjects, aortic allometric volume (standardized β = 0.665/decade; highest mean |SHAP| = 6.38) and mean diameters demonstrated the strongest associations with chronological aging, accompanied by progressive aortic straightening. After adjusting for age and sex, hypertension emerged as the most significant independent driver of geometric remodeling, notably expanding diameters, volume, and arch width (all p < 1×10-6). The impact of smoking was substantially attenuated after age adjustment. Furthermore, higher high-density lipoprotein cholesterol (HDL-C) was independently associated with less-than-expected aortic dilation, whereas elevated fasting glucose, total cholesterol, and inflammatory markers were significantly linked to accelerated aortic aging (FDR < 0.05). Allometric volume and diameter are highly sensitive markers for thoracic aortic aging. Hypertension independently accelerates geometric remodeling, whereas smoking's impact is largely mediated by overall aging. Routine metabolic and inflammatory laboratory panels can facilitate the early identification of accelerated vascular aging.Disease&agpFor image description, please refer to the figure legend and surrounding text.Lab&agpFor image description, please refer to the figure legend and surrounding text.

Read PDF

Similar papers

Open access Oct 2026

AI-derived cardiovascular age from point-of-care ultrasound uncovers accelerated cardiometabolic aging

AI-derived CV biological age from FoCUS identifies subclinical cardiometabolic vulnerability independent of chronological age in asymptomatic adults, and may enhance personalized risk profiling and guide early preventive interventions in asymptomatic adults.

R. Amster, D. Simanovsky, R. Loutati et al. · 0 citations
Open access Oct 2026

Accelerated biological aging increases the 10-year mortality risk in patients with coronary artery disease after percutaneous coronary intervention

Biological age (BA) is a composite indicator integrating multiple clinical and biochemical biomarkers to quantify physiological aging and reflects overall health status more accurately than chronological age (CA). This study aimed to evaluate the associations between three biological age algorithms and 10-...

N. Xu, M.-L. Liu, X.-F. Tang et al. · 0 citations
Open access Oct 2026

Prognostic value of biological aging in TAVR for aortic stenosis: a combined prospective and retrospective cohort study

Biological aging (BA) is a comprehensive marker reflecting systemic physiological aging, offering critical context for individual variability based on chronological age. A series of studies have demonstrated that BA is associated with the prognosis of cardiovascular diseases and outcomes following percutaneous co...

R. Tang, H. Li, W. Li et al. · 0 citations
Open access Oct 2026

CVMI-age quantifies multidimensional cardiovascular aging and predicts cardiovascular events: a Chinese community-based cohort study

Cardiovascular (CV) aging is a complex biological process driven by hemodynamic stress, metabolic dysregulation, and chronic inflammation. Traditional vascular aging models relying solely on arterial stiffness often fail to capture the systemic immuno-metabolic burden, leaving a gap in quantifying the residual CV...

H. Xie, F. Fan, J. Jia et al. · 0 citations
Open access Oct 2026

Biological age acceleration and progression of cardiovascular-kidney-metabolic syndrome: a multi-cohort comparative analysis of phenoage and KDMAge

Accelerated biological aging was robustly associated with advanced CKM across all populations, with PhenoAge consistently outperforming KDMAge, and PhenoAge demonstrated superior risk stratification capability compared to KDMAge, highlighting its potential utility in early risk assessment.

Y. Chen, W. Li, W. Chen et al. · 0 citations
Review Open access Oct 2026

Chronological and biological age in elderly cardiological patients: pathophysiological mechanisms, assessment methods, and clinical significance of disparity

Chronological age remains one of the most important determinants of cardiovascular risk; however, in elderly and senile cardiac patients it does not always reflect the individual rate of aging, functional reserves and pathophysiological vulnerability of the cardiovascular system. Biological age is considered an integra...

S. Voloshin, V. Polyakova, S. M. Alekseev · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.